Abstract
The high expression of somatostatin receptor 2 (SST2) in growth hormone (GH)-secreting tumors represents the rationale for the clinical use of somatostatin analogs (SSAs) in acromegaly. Recently, the cytoskeletal protein Filamin A (FLNA) has emerged as key modulator of the responsiveness of GH-secreting pituitary tumors to SSAs by regulating SST2 signaling and expression. The aim of this study was to explore FLNA involvement in SST2 intracellular trafficking in tumor somatotroph cells. By biotinylation assay, we found that FLNA silencing abolished octreotide-mediated SST2 internalization in rat GH3 cell line (28.0 ± 2.7 vs. 4 ± 4.3% SST2 internalization, control versus FLNA small interfering RNAs (siRNA) cells, respectively, p < 0.001) and human GH-secreting primary cultured cells (70.3 ± 21.1 vs. 24 ± 19.2% SST2 internalization, control versus FLNA siRNA cells, respectively, p < 0.05). In addition, confocal imaging revealed impaired SST2 recycling to the plasma membrane in FLNA silenced GH3 cells. Coimmunoprecipitation and immunofluorescence experiments showed that FLNA, as well as β-arrestin2, is timely dependent recruited to octreotide-stimulated SST2 receptors both in rat and human tumor somatotroph cells. Although FLNA expression knock down did not prevent the formation of β-arrestin2-SST2 complex in GH3 cells, it significantly impaired efficient SST2 loading into cytosolic vesicles positive for the early endocytic and recycling markers Rab5 and 4, respectively (33.7 ± 8.9% down to 25.9 ± 6.9%, p < 0.05, and 28.4 ± 7.4% down to 17.6 ± 5.7%, p < 0.01, for SST2-Rab5 and SST2-Rab4 colocalization, respectively, in control versus FLNA siRNA cells). Altogether these data support an important role for FLNA in the mediation of octreotide-induced SST2 trafficking in GH-secreting pituitary tumor cells through Rab5 and 4 sorting endosomes.
References
1.
Günther
T
, Tulipano
G
, Dournaud
P
, Bousquet
C
, Csaba
Z
, Kreienkamp
HJ
, et al. International union of basic and clinical pharmacology. cv. somatostatin receptors: structure, function, ligands, and new nomenclature
. Pharmacol Rev
. 2018
Oct
;70
(4
):763
–835
.
[PubMed]
0031-69972.
Körner
M
, Eltschinger
V
, Waser
B
, Schonbrunn
A
, Reubi
JC
. Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography
. Am J Surg Pathol
. 2005
Dec
;29
(12
):1642
–51
.
[PubMed]
0147-51853.
Gadelha
MR
, Kasuki
L
, Korbonits
M
. Novel pathway for somatostatin analogs in patients with acromegaly
. Trends Endocrinol Metab
. 2013
May
;24
(5
):238
–46
.
[PubMed]
1043-27604.
Gadelha
MR
, Wildemberg
LE
, Bronstein
MD
, Gatto
F
, Ferone
D
. Somatostatin receptor ligands in the treatment of acromegaly
. Pituitary
. 2017
Feb
;20
(1
):100
–8
.
[PubMed]
1386-341X5.
Gatto
F
, Feelders
RA
, van der Pas
R
, Kros
JM
, Waaijers
M
, Sprij-Mooij
D
, et al. Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly
. J Clin Endocrinol Metab
. 2013
Jan
;98
(1
):E66
–71
.
[PubMed]
0021-972X6.
Wildemberg
LE
, Neto
LV
, Costa
DF
, Nasciuti
LE
, Takiya
CM
, Alves
LM
, et al. Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs
. J Endocrinol Invest
. 2013
Jan
;36
(1
):38
–43
.
[PubMed]
1720-83867.
Colao
A
, Auriemma
RS
, Lombardi
G
, Pivonello
R
. Resistance to somatostatin analogs in acromegaly
. Endocr Rev
. 2011
Apr
;32
(2
):247
–71
.
[PubMed]
0163-769X8.
Peverelli
E
, Treppiedi
D
, Giardino
E
, Vitali
E
, Lania
AG
, Mantovani
G
. Dopamine and somatostatin analogues resistance of pituitary tumors: focus on cytoskeleton involvement
. Front Endocrinol (Lausanne)
. 2015
Dec
;6
:187
.
[PubMed]
1664-23929.
Irannejad
R
, Tomshine
JC
, Tomshine
JR
, Chevalier
M
, Mahoney
JP
, Steyaert
J
, et al. Conformational biosensors reveal GPCR signalling from endosomes
. Nature
. 2013
Mar
;495
(7442
):534
–8
.
[PubMed]
0028-083610.
Godbole
A
, Lyga
S
, Lohse
MJ
, Calebiro
D
. Internalized TSH receptors en route to the TGN induce local Gs-protein signaling and gene transcription
. Nat Commun
. 2017
Sep
;8
(1
):443
.
[PubMed]
2041-172311.
Nakamura
F
, Stossel
TP
, Hartwig
JH
. The filamins: organizers of cell structure and function
. Cell Adhes Migr
. 2011
Mar-Apr
;5
(2
):160
–9
.
[PubMed]
1933-691812.
Stossel
TP
, Condeelis
J
, Cooley
L
, Hartwig
JH
, Noegel
A
, Schleicher
M
, et al. Filamins as integrators of cell mechanics and signalling
. Nat Rev Mol Cell Biol
. 2001
Feb
;2
(2
):138
–45
.
[PubMed]
1471-007213.
Peverelli
E
, Mantovani
G
, Vitali
E
, Elli
FM
, Olgiati
L
, Ferrero
S
, et al. Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs
. J Clin Endocrinol Metab
. 2012
Mar
;97
(3
):967
–77
.
[PubMed]
0021-972X14.
Peverelli
E
, Giardino
E
, Treppiedi
D
, Vitali
E
, Cambiaghi
V
, Locatelli
M
, et al. Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells
. Endocrinology
. 2014
Aug
;155
(8
):2932
–41
.
[PubMed]
0013-722715.
Coelho
MC
, Vasquez
ML
, Wildemberg
LE
, Vázquez-Borrego
MC
, Bitana
L
, Camacho
AH
, et al. Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles
. Sci Rep
. 2019
Feb
;9
(1
):1122
.
[PubMed]
2045-232216.
Treppiedi
D
, Jobin
ML
, Peverelli
E
, Giardino
E
, Sungkaworn
T
, Zabel
U
, et al. Single-molecule microscopy reveals dynamic flna interactions governing sttr2 clustering and internalization
. Endocrinology
. 2018
Aug
;159
(8
):2953
–65
.
[PubMed]
0013-722717.
Tulipano
G
, Stumm
R
, Pfeiffer
M
, Kreienkamp
HJ
, Höllt
V
, Schulz
S
. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes
. J Biol Chem
. 2004
May
;279
(20
):21374
–82
.
[PubMed]
0021-925818.
Pöll
F
, Lehmann
D
, Illing
S
, Ginj
M
, Jacobs
S
, Lupp
A
, et al. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation
. Mol Endocrinol
. 2010
Feb
;24
(2
):436
–46
.
[PubMed]
0888-880919.
Kao
YJ
, Ghosh
M
, Schonbrunn
A
. Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists
. Mol Endocrinol
. 2011
Jun
;25
(6
):1040
–54
.
[PubMed]
0888-880920.
Lehmann
A
, Kliewer
A
, Schütz
D
, Nagel
F
, Stumm
R
, Schulz
S
. Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor
. Mol Cell Endocrinol
. 2014
Apr
;387
(1-2
):44
–51
.
[PubMed]
0303-720721.
Gatto
F
, Feelders
R
, van der Pas
R
, Kros
JM
, Dogan
F
, van Koetsveld
PM
, et al. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly
. Endocrinology
. 2013
Dec
;154
(12
):4715
–25
.
[PubMed]
0013-722722.
Gatto
F
, Biermasz
NR
, Feelders
RA
, Kros
JM
, Dogan
F
, van der Lely
AJ
, et al. Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly
. Eur J Endocrinol
. 2016
May
;174
(5
):651
–62
.
[PubMed]
0804-464323.
Coelho
MC
, Vasquez
ML
, Wildemberg
LE
, Vázquez-Borrego
MC
, Bitana
L
, Camacho
AH
, et al. Molecular evidence and clinical importance of β-arrestins expression in patients with acromegaly
. J Cell Mol Med
. 2018
Apr
;22
(4
):2110
–6
.
[PubMed]
1582-183824.
Kim
KM
, Gainetdinov
RR
, Laporte
SA
, Caron
MG
, Barak
LS
. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation
. J Biol Chem
. 2005
Apr
;280
(13
):12774
–80
.
[PubMed]
0021-925825.
Scott
MG
, Pierotti
V
, Storez
H
, Lindberg
E
, Thuret
A
, Muntaner
O
, et al. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins
. Mol Cell Biol
. 2006
May
;26
(9
):3432
–45
.
[PubMed]
0270-730626.
Lesche
S
, Lehmann
D
, Nagel
F
, Schmid
HA
, Schulz
S
. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro
. J Clin Endocrinol Metab
. 2009
Feb
;94
(2
):654
–61
.
[PubMed]
0021-972X27.
Hutagalung
AH
, Novick
PJ
. Role of Rab GTPases in membrane traffic and cell physiology
. Physiol Rev
. 2011
Jan
;91
(1
):119
–49
.
[PubMed]
0031-933328.
Kjos
I
, Vestre
K
, Guadagno
NA
, Borg Distefano
M
, Progida
C
. Rab and Arf proteins at the crossroad between membrane transport and cytoskeleton dynamics
. Biochim Biophys Acta Mol Cell Res
. 2018
Jul
;1865
(10
):1397
–409
.
[PubMed]
0167-488929.
Tower-Gilchrist
C
, Lee
E
, Sztul
E
. Endosomal trafficking of the G protein-coupled receptor somatostatin receptor 3
. Biochem Biophys Res Commun
. 2011
Oct
;413
(4
):555
–60
.
[PubMed]
0006-291X30.
Derivery
E
, Sousa
C
, Gautier
JJ
, Lombard
B
, Loew
D
, Gautreau
A
. The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex
. Dev Cell
. 2009
Nov
;17
(5
):712
–23
.
[PubMed]
1534-580731.
Gomez
TS
, Billadeau
DD
. A FAM21-containing WASH complex regulates retromer-dependent sorting
. Dev Cell
. 2009
Nov
;17
(5
):699
–711
.
[PubMed]
1534-580732.
Cambiaghi
V
, Vitali
E
, Morone
D
, Peverelli
E
, Spada
A
, Mantovani
G
, et al. Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line
. Endocrine
. 2017
Apr
;56
(1
):146
–57
.
[PubMed]
1355-008X33.
Peverelli
E
, Giardino
E
, Treppiedi
D
, Catalano
R
, Mangili
F
, Locatelli
M
, et al. A novel pathway activated by somatostatin receptor type 2 (SST2): inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment
. Int J Cancer
. 2018
May
;142
(9
):1842
–52
.
[PubMed]
0020-713634.
Lin
R
, Karpa
K
, Kabbani
N
, Goldman-Rakic
P
, Levenson
R
. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A
. Proc Natl Acad Sci USA
. 2001
Apr
;98
(9
):5258
–63
.
[PubMed]
0027-842435.
Lin
R
, Canfield
V
, Levenson
R
. Dominant negative mutants of filamin A block cell surface expression of the D2 dopamine receptor
. Pharmacology
. 2002
Dec
;66
(4
):173
–81
.
[PubMed]
0031-701236.
Cho
EY
, Cho
DI
, Park
JH
, Kurose
H
, Caron
MG
, Kim
KM
. Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor
. Mol Endocrinol
. 2007
Sep
;21
(9
):2242
–54
.
[PubMed]
0888-880937.
Onoprishvili
I
, Andria
ML
, Kramer
HK
, Ancevska-Taneva
N
, Hiller
JM
, Simon
EJ
. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking
. Mol Pharmacol
. 2003
Nov
;64
(5
):1092
–100
.
[PubMed]
0026-895X38.
Liu
G
, Thomas
L
, Warren
RA
, Enns
CA
, Cunningham
CC
, Hartwig
JH
, et al. Cytoskeletal protein ABP-280 directs the intracellular trafficking of furin and modulates proprotein processing in the endocytic pathway
. J Cell Biol
. 1997
Dec
;139
(7
):1719
–33
.
[PubMed]
0021-952539.
Minsaas
L
, Planagumà
J
, Madziva
M
, Krakstad
BF
, Masià-Balagué
M
, Katz
AA
, et al. Filamin a binds to CCR2B and regulates its internalization
. PLoS One
. 2010
Aug
;5
(8
):e12212
.
[PubMed]
1932-620340.
Csaba
Z
, Lelouvier
B
, Viollet
C
, El Ghouzzi
V
, Toyama
K
, Videau
C
, et al. Activated somatostatin type 2 receptors traffic in vivo in central neurons from dendrites to the trans Golgi before recycling
. Traffic
. 2007
Jul
;8
(7
):820
–34
.
[PubMed]
1398-921941.
Lelouvier
B
, Tamagno
G
, Kaindl
AM
, Roland
A
, Lelievre
V
, Le Verche
V
, et al. Dynamics of somatostatin type 2A receptor cargoes in living hippocampal neurons
. J Neurosci
. 2008
Apr
;28
(17
):4336
–49
.
[PubMed]
0270-647442.
Pons
M
, Izquierdo
I
, Andreu-Carbó
M
, Garrido
G
, Planagumà
J
, Muriel
O
, et al. Phosphorylation of filamin A regulates chemokine receptor CCR2 recycling
. J Cell Sci
. 2017
Jan
;130
(2
):490
–501
.
[PubMed]
0021-9533© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
